Crossroads Health Ventures

What Crossroads Health Ventures does

Crossroads Health Ventures (CHV) is an early-stage venture capital firm that invests in U.S.-based life sciences startups, with operational roots in Indianapolis, Indiana, and structural sponsorship from BioCrossroads within the Central Indiana Corporate Partnership (CICP) ecosystem. The firm targets pre-seed and early-stage life sciences companies whose strategic fit aligns with the priorities of its limited partners, and supplements capital with curated introductions to the CICP network of more than 100 corporations — a distribution differentiator that the firm positions as its primary value-add beyond pure financial investment. CHV's stated investment criteria are explicit: life sciences sector innovation, early-stage U.S.-based companies, and alignment with strategic LPs.

The firm operates a single unified offering — early-stage life sciences venture investment — supported by an inbound Startup Inquiry Form (crossroadshealthventures.com/chv-form/) as the primary capital-deployment channel and an outbound sourcing motion via the CICP, BioCrossroads, TechPoint (Indiana Founders Network), and AgriNovus Indiana ecosystem. There is no proprietary technology platform, AI/ML infrastructure, or API; the underlying "product" is fund economics (management fees and carried interest on equity appreciation in portfolio companies). Revenue mechanics, fund size, ticket sizes, and management fee structures are not publicly disclosed.

CHV is led by Managing Directors Ting Gootee (also EVP Digital Adoption at CICP; CFA, CAIA) and Vince Wong (JD, MBA), alongside Principal Samantha Ginther (MPH), and is operationally supported by senior figures embedded in BioCrossroads (Emily Atkinson, PhD), TechPoint (Chelsea Linder), and AgriNovus Indiana (Christy Wright). The team holds dual roles across the Indiana life sciences ecosystem, which reinforces the firm's deal-sourcing and value-add capabilities but also signals that CHV is, at present, more of a coordinated initiative within an existing ecosystem than a standalone institutional asset manager.

Name

Crossroads Health Ventures

Legal name

Crossroads Health Ventures

Website

https://crossroadshealthventures.com

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

1–10 employees

Short description

Crossroads Health Ventures is an Indianapolis-based, early-stage venture capital firm investing in U.S. life sciences startups, sponsored by BioCrossroads within the CICP ecosystem. It deploys capital aligned with strategic LP priorities and supplements investment with introductions to a network of 100+ corporations.

Ownership category

akta.pro rank

Product category

Life Sciences Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

akta.pro primary industry

Captive CVC Fund (Dedicated corporate fund structure) (FSANAHAB)

akta.pro secondary industry

Corporate Innovation & Technology Scouting Units (with investment mandate) (FSANAHAI)

Keywords

• Venture capital investing
• Life sciences funding
• Early-stage startups
• Healthcare innovation
• Strategic LP alignment

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Venture investment returns (capital gains / fund economics): As a venture fund investing in early-stage, U.S.-based life sciences companies aligned with strategic LPs, CHV generates returns through equity appreciation in portfolio companies and typical fund economics (management fees and carried interest on successful exits). No specific fee schedule or return figures are publicly disclosed.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Crossroads Health Ventures (CHV) is an early-stage venture capital firm that invests in U.S.-based life sciences startups aligned with strategic limited partners within the Central Indiana Corporate Partnership (CICP) network. The fund provides early-stage capital along with curated corporate introductions and strategic guidance drawn from a network of 100+ corporations and 300+ startups supported annually through CICP.

Product overview

Crossroads Health Ventures (CHV) operates a single unified venture investment offering rather than a platform-plus-modules product architecture. Its core offering is early-stage, U.S.-based life sciences investing for founders, with support layered on through the Central Indiana Corporate Partnership (CICP) network. The CHV Inquiry Form serves as a sub-product/intake tool, enabling prospective portfolio startups to submit inquiries directly to the CHV team via the website.

Differentiator

Problem solved

Functional benefit

Products and services

• Crossroads Health Ventures (CHV) Early-Stage Life Sciences Investment Program Early-stage venture capital investment program for U.S.-based life sciences startups, providing capital aligned with strategic LPs and access to the CICP network of 100+ corporations for strategic guidance and introductions.

Quantifiable outcome

• 300+ startups supported annually through the CICP network
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Lux Capital: Early-stage venture firm with deep life sciences and biotech investing alongside frontier tech. Comparable to CHV in early-stage, science-heavy investment philosophy and U.S. deployment mandate.
• ARCH Venture Partners: Premier U.S. life sciences venture firm investing across biotech, genomics, and health tech from seed through growth. Comparable as a specialized life sciences VC, though significantly larger and more established than CHV.
• Section 32: Venture fund investing at the frontier of technology, healthcare, and life sciences. Comparable to CHV as an early-stage, thesis-driven life sciences investor, though with substantially larger fund size.
• Atlas Venture: Early-stage life sciences venture firm focused on building biotech startups. Directly comparable to CHV in stage focus (seed/early) and life sciences specialization, though with a far longer track record.

Regional players

• BioGenerator: St. Louis-based seed and early-stage life sciences investor and startup creator. Closest comparable to CHV as a regional life sciences venture platform operating within a state-level innovation ecosystem.
• Elevate Ventures: Indiana-focused early-stage venture fund and ecosystem builder. Closely comparable to CHV as an Indiana-rooted, ecosystem-anchored early-stage investor, though broader across sectors beyond life sciences.

Broad incumbents

• Flagship Pioneering: Large life sciences innovation platform that originates and funds biotech companies. Comparable as a life sciences-focused venture creator, though operating at vastly greater scale and with proprietary origination methods.
• Khosla Ventures: Large U.S. venture firm with a meaningful life sciences and healthcare practice. Comparable as an early-stage investor in science-driven companies, though operating across many sectors at much greater scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/crossroads-health-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Crossroads Health Ventures